Study of Bitopertin in Participants With EPP or XLP (APOLLO)

NCT06910358 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

183

Enrollment

INDUSTRY

Sponsor class

Conditions

Erythropoietic Protoporphyria (EPP)
X-Linked Protoporphyria (XLP)

Interventions

DRUG: Placebo
DRUG: DISC-1459

Sponsor

Disc Medicine, Inc